Here, using HOXA9-reporter-based genome-wide CRISPR/Cas9 screens, we identified that RBM5 is a positive regulator for maintaining HOXA9 expression and acute myeloid leukemia survival. This evidence concerns the gene RBM5 and acute myeloid leukemia.